Embedding access tools at prescribing reduces manual enrollment, portal switching, and late activation, enabling faster ...

Brent Wilhelm of Cencora discusses why available inventory still leads to shortages, and how tighter distributor-manufacturer integration and AI could close the gap. In part 1 of a 3-part interview ...

In this week's Pharma Pulse, CVS Caremark settles with the FTC over rebates and TrumpRx, Germany more than doubles its drug rebate, and the FDA proposes a registration rule. Welcome to Pharma Pulse, a ...

PwC's Roel van den Akker says pharma M&A ran beyond expectations in the first half of 2026, with dealmaking potentially on pace to hit $300 billion in H2. Pharmaceutical Commerce recently checked in ...

Lilly will pay $6.75 per share (~26% premium), totaling $2.8 billion upfront with up to $1 billion milestone-based consideration, and expects closure in Q3 2026. Federal acceleration of psychedelic ...

Specialty medicines comprise ~75% of ~7,000 pipeline assets, with nearly 180 advanced therapies expected by 2030, accelerating demand for scalable, operationally sustainable distribution models.

Traditional wholesaler-centric, pallet-based logistics is giving way to integrated, commercialization-aligned models that manage order-to-cash complexity and optimize gross-to-net outcomes. AI ...

A fixed 15.5% manufacturer rebate on patented branded drugs replaces a proposed variable, expenditure-linked mechanism after coordinated industry pressure and threats to curtail German investment and ...

Pairing Tennr referral intake and documentation automation with TailorMed affordability tooling is designed to surface access barriers earlier and shorten time-to-therapy for infusion and specialty ...